Start-up in Thailand discusses how it's developing a plant-based Covid vaccine
Dr. Suthira Taychakhoonavudh of Baiya Phytopharm discusses the progress the company has made on clinical trials for what could be Thailand's first plant-based Covid vaccine.
UP NEXT
NOW PLAYING: Top Stocks
Start-up in Thailand discusses how it's developing a plant-based Covid vaccine
CNBC
UP NEXT
-
Lowe's reports mixed first-quarter earnings
CNBC
-
The Pre-Markets Rundown: May 18, 2022
-
Elon Musk's fake account argument 'doesn't hold water,' analyst says
-
Former Finnish PM: Russia does not see Finnish and Swedish accession to NATO as a military threat
-
Sea Ltd.'s first quarter revenue beats estimates, but losses widen
-
We already are in a recession, investment firm CIO says
-
Citi sees the UK as a 'proxy for value' even as rates go up
-
Musk still wants to get the deal done but at a lower price, says analyst
-
Indonesia's palm oil export ban isn't a sign of 'creeping protectionism,' says former finance minister
-
SGX aims to launch EV battery materials contracts by this year
-
ETF Securities discusses the launch of crypto ETFs in Australia
-
Australian government has to do 'a lot of shoveling' to help people cope with rising living costs
-
Chinese regulators may have realized they were 'too heavy-handed' in tech sector: Investment firm
-
It's now a lot easier to get clarity on the Chinese market than the U.S. one, says UBS
-
A CEO opened up about her divorce at work – and she says it was good for business
-
More employees want flexible working arrangements, says WeWork
